Pelvic inflammatory disease in adolescents

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 5, 2006, Pages 503-510

  Gray Swain, M Rosanna ^a   Peipert, Jeffrey F ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adnexitis; Adolescents; Endometritis; Salpingitis; Sexually transmitted diseases

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; SULBACTAM;

ADOLESCENT DISEASE; CHLAMYDIA TRACHOMATIS; DISEASE PREDISPOSITION; HUMAN; MICROBIOLOGY; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRICHOMONIASIS;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHILD; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GONORRHEA; HEALTH EDUCATION; HUMANS; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 33748278192     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000242952.87125.69     Document Type: Review

References (57)

1. Center for Disease Control and Prevention. Pelvic Inflammatory Disease - CDC Fact Sheet. Atlanta, GA: May 2006.
2. Botte J, Peipert JF. Epidemiology. In: Sweet RL, Wiesenfeld HC, editors. Pelvic Inflammatory Disease. London: Taylor & Francis; 2006. pp. 1-18. This is a comprehensive textbook which covers the epidemiology, microbiology, pathogenesis, pathology, sequelae, management and prevention of PID. Subclincal PID, tubo-ovarian abscesses and postprocedural upper genital tract infection are also reviewed.
3. Centers for Disease Control and Prevention. STD Surveillance 2004. National Report. Gonorrhea. Atlanta, GA: 2004
4. Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females Epidemiology, pathogenesis, diagnosis, treatment and sequelae. Pediatr Clin North Am 1989; 36:513-532.
5. World Health Organization. Pelvic inflammatory disease in nongonococcal urethritis and other selected sexually transmitted diseases of public health importance. WHO Tech Rep Ser 1981; 660-689.
6. Marks C, Tideman RL, Estcourt CS, et al. Assessment of risk for pelvic inflammatory disease in an urban sexual health population. Sex Trans Dis 2000; 76:470-473.
7. Ness RB, Smith KJ, Chang CH, et al. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006; 63:137-142. Investigators recruited 1170 women age 13-36 at high risk for chlamydial infection and followed them for 3 years for incident PID. Based on a multivariable analysis, risk factors for PID included: age at first intercourse of 15 years or less, current cervicitis, history of PID, annual income less than $20 000, smoking, medroxyprogesterone acetate use, and sex with menses.
8. Eschenbach DA. Epidemiology of acute pelvic inflammatory disease. Banff: International Society for STD Research; 1991.
9. Centers for Disease Control and Prevention. STD Surveillance 2004. Special Focus Profiles. Adolescents and young. Atlanta, GA: 2004
10. Peipert JF. Genital chlamydial Infections. N Eng J Med 2003; 349:2524-2530.
11. Berman SM, Hein K. Adolescents and STD's. In: Holmes KK, Sparling PF, Märdh PA, et al., editors. Sexually Transmitted Diseases. New York: McGraw-Hill; 1999. pp. 129-142.
12. Elkin D. Cognitive development. In: Friedman SB, Fisher M, Schonberg SK, editors. Comprehensive Adolescent Healthcare. St Louis: Quality Medical Publishing; 1992. pp. 24-26.
13. Cromwell PF, Risser WL, Risser JMH. Prevalence and incidence of pelvic inflammatory disease in incarcerated adolescents. Sex Transm Dis 2002; 29:391-396.
14. Suss AL, Homel P, Hammerschlag M, et al. Risk factors for pelvic inflammatory disease in inner-city adolescents. Sex Transm Dis 2000; 27:289-291.
15. American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine. Recommendations for preventive pediatric heath care (RE9939). Pediatrics 2000; 105:645.
16. Sweet RL, Gibbs RS. Pelvic inflammatory disease. In: Sweet RL, Gibbs RS, editors. Infectious Diseases of the Female Genital Tract, 4th edition Philadelphia: Lippincott, Williams and Wilkins; 2002. pp. 368-412.
17. Washington AE, Cates W, Zadi AA. Hospitalizations for pelvic inflammatory disease Epidemiology and trends in the United States. JAMA 1984; 251:2529-2533.
18. Stamm W, Guinan M, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhea on simultaneous infection with Chlamydia trachomatis. N Eng J Med 1984; 310:545-549.
19. Peipert JF, Montagno A, Cooper AS, Sung J. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-1187.
20. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004; 104:761-769.
21. Ness R, Kip K, Hillier SL, et al. A Cluster Analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005; 162:585-590. This study investigates the controversy surrounding the association of bacterial vaginosis (BV) and PID. This was a multicentre study that collected serial vaginal swabs for Gram's stain and culture and correlated the findings with cases of PID. Carriage of non-BV-associated organisms did not alter one's risk for PID. Heavy growth of BV-association organisms resulted in an increased risk for PID (OR=2.0, CI=1.2, 3.5). When heavy growth was combined with a new sex partner the odds ratio increased to 8.8 (CI=1.1, 69.2).
22. Hebb JK, Cohen CR, Astete SG, et al. Detection of novel organisms associated with salpingitis by use of 16S rDNA polymerase chain reaction. J Infect Dis 2004; 190:2109-2120.
23. Center for Disease Control and Prevention. STD Surveillance 2004 National Profile: Chlamydia. Atlanta, GA: 2004.
24. Moodley P, Wilkinson D, Connolly C, et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infec Dis 2002; 34:519-522.
25. Paisarntantiwong R, Brockman S, Clarke L, et al. The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis. Sex Transm Dis 1995; 22:344-347.
26. Moore MM, Cardosi RJ, Barrionuevo MJ. Tubo-ovarian abscess in an adolescent virgin female. Arch Pediatr Adolesc Med 1999; 153:91-92.
27. Algren SD, Strickland JL. Beta hemolytic streptococcus group f causing pelvic inflammatory disease in a 14-year-old girl. J Pediatr Adolesc Gynecol 2005; 18:117-119.
28. Fumino S, Iwai N, Tokiwa K, et al. Tubo-ovarian abscess after colonic vaginoplasty for high cloacal anomaly in a 13-year-old girl. Eur J Pediatr Surg 2002; 12:345-347.
29. Tandan T, Pollard AJ,Money DM, et al. Pelvic inflammatory disease associated with Enterobius vermicularis. Arch Dis Child 2002; 86:439-440.
30. Rossbach HC, Mastry M, Barnes J, et al. Foreign matter salpingitis 3 years after typhlitis. J Pediatr Hematol Oncol 2001; 23:253-254.
31. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhea infections-2002. MMWR Recomm Rep 2002; 51 (RR-15):1-38.
32. Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001; 28:321-325.
33. Sweet RL, Shachter J, Robbie MO. Failure of beta-lactams antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 1983; 250:2641-2645.
34. Henry-Suchet J, Loffredo V. Chlamydia and mycoplasma genital infection in salpingitis and tubal sterility. Lancet 1980; 1:539.
35. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-463.
36. Center for Disease Control and Prevention. Pelvic Inflammatory Disease. 2006 Sexually Transmitted Disease Treatment Guidelines (in press).
37. Kahn JA, Chiang VW, Shrier LA, et al. Microlaparoscopy with conscious sedation in adolescents with suspected pelvic inflammatory disease. J Pediatr Adolesc Gynecol 1999; 12:149-154.
38. Uslu H, Varoglu E, Kadanali S, et al. 99mTc-HMPAO labeled leucocyte scintigraphy in the diagnosis of pelvis inflammatory disease. Nucl Med Commun 2006; 27:179-183. This study investigated a novel diagnostic modality for PID in 15 women with suspected PID. Scintigraphy with 99mTc-HMPAO labeled leukocytes was used to detected PID with a reported 100% sensitivity, 90% specificity and overall accuracy of 93%. Positive scintigraphic uptake revealed circular areas of increased leukocyte accumulation on the pelvis consistent with inflammation. Use of this rapid and highly accurate diagnostic modality may assist the clinician in determining whether operative or conservative management is appropriate in difficult diagnostic cases where nuclear medicine services are readily available.
39. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results for the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186:929-937.
40. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005; 106:573-580. The PEACH study was an RCT of inpatient and outpatient therapy for PID. This analysis included expanded follow-up for a mean of 84 months of follow-up. Outpatient therapy did not adversely impact reproductive outcomes (that is, fertility, ectopic, PID recurrence, chronic pelvic pain). This was true even in subgroups of adolescents and women without a previous live birth.
41. Hemsel DL, Ledger WJ, Martens MG, et al. Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease. Clin Infect Dis 2001; 32:103-107.
42. Gonik B, Pokorny S, Garcia S, et al. Pelvic inflammatory disease in the adolescent. Tex Med 1987; 83:25-26.
43. Westrom L. Effect of acute pelvic inflammatory disease on infertility. Am J Obstet Gynecol 1975; 121:707-713.
44. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 139:880-892.
45. Westrom L, Joeseof R, Reynolds G, et al. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
46. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-463.
47. Patton DL, Moore DE, Spadoni LR, et al. A comparison of the Fallopian tube's response to overt and silent salpingitis. Obstet Gynecol 1989; 73:622-630.
48. Westrom LV. Sexually transmitted diseases and infertility. Sex Transm Dis 1994; 21:S32-S37.
49. Bernstien R, Kennedy WR, Waldron J. Acute pelvic inflammatory disease: a clinical follow up. Int J Fertil 1987; 32:229-232.
50. Chow JM, Yonkura L, Richwald GA, et al. The association between Chlamydia trachomatis and ectopic pregnancy. JAMA 1990; 263:3164-3167.
51. Landers DV, Sweet RL. Tuboovarian abscess: contemporary approach to management. Rev Infect Dis 1983; 5:876-884.
52. Gerber B, Krause A. A study of second-look laparoscopy after acute salpingitis. Arch Gynecol Obstet 1996; 258:193-200.
53. Heinonen PK, Leinonen M. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole. Arch Gynecol Obstet 2003; 268:284-288.
54. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health 2004; 36:6-10.
55. US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prevent Med 2001; 20 (Suppl):90-94.
56. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-1366.
57. Hillis SD, Joesoef R, Marchbanks PA, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168:1503-1509.